Epithelial Cell Adhesion Molecule (EpCAM) Expression Can Be Modulated via NFκB

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Epithelial cell adhesion molecule (EpCAM) is a key proliferation marker in various cancers.
• Acute lymphoblastic leukemia (ALL) exhibits EpCAM expression.
• Costunolide, a natural sesquiterpene lactone, possesses anticancer properties.

Purpose of the Study:

• To investigate the effect of costunolide on EpCAM expression in leukemia cells.
• To explore the molecular mechanisms underlying costunolide's action on EpCAM and its downstream targets.

Main Methods:

• Quantitative Polymerase Chain Reaction (qPCR) to assess gene expression.
• Cell culture experiments using Jurkat cells (a leukemia cell line).
• In silico molecular docking studies to predict interactions.

Main Results:

• Costunolide treatment downregulated EpCAM, Myc, and TERT gene expression in Jurkat cells.
• No significant change in telomere length was observed after 72 hours of costunolide treatment.
• In silico analysis indicated hydrophobic interactions between costunolide, EpCAM, and Myc.
• Costunolide reduced the expression of NFκB, a transcription factor regulating EpCAM, Myc, and TERT.

Conclusions:

• Costunolide demonstrates potential as a therapeutic agent for leukemia by inhibiting EpCAM signaling.
• The mechanism involves the downregulation of NFκB and its downstream targets.
• Further research is warranted to explore costunolide's therapeutic efficacy in leukemia.